
1.山西中医药大学多发性硬化益气活血重点研究室/神经生物学研究中心,山西晋中 030619
2.复旦大学华山医院神经病学研究所,上海 200025
3.美国印第安纳大学医学院,印第安纳波利斯 46202
Ma Cun-Gen, E-mail: macungen@sxtcm.edu.cn
Fan Hui-Jie, E-mail: fanhuijie@sxtcm.edu.cn
扫 描 看 全 文
茹意, 谢良骐, 王新亮, 等. 五味子醇甲对小鼠神经管畸形的预防作用及其机制研究[J]. 解放军医学杂志, 2023, 48(12): 1370-1377.
Ru Yi,Xie Liang-Qi,Wang Xin-Liang,et al.Study on the preventive effect of schisandrin on neural tube defects in mice and its mechanism[J].Medical Journal of Chinese People′s Liberation Army,2023,48(12):1370-1377.
茹意, 谢良骐, 王新亮, 等. 五味子醇甲对小鼠神经管畸形的预防作用及其机制研究[J]. 解放军医学杂志, 2023, 48(12): 1370-1377. DOI: 10.11855/j.issn.0577-7402.0333.2023.0828.
Ru Yi,Xie Liang-Qi,Wang Xin-Liang,et al.Study on the preventive effect of schisandrin on neural tube defects in mice and its mechanism[J].Medical Journal of Chinese People′s Liberation Army,2023,48(12):1370-1377. DOI: 10.11855/j.issn.0577-7402.0333.2023.0828.
目的,2,探究五味子醇甲(SCH)对小鼠神经管畸形(NTDs)的预防作用及其机制。,方法,2,将C57BL/6小鼠按照雌雄2∶1比例合笼,将交配后有阴栓的雌鼠(孕鼠)随机分为对照组、模型组、SCH组与叶酸组,每组9只。除对照组外,在孕鼠妊娠7.5 d(E 7.5 d)时腹腔注射全反式维甲酸(atRA)(7.5 mg/kg)诱导胎鼠NTDs模型;在E 0.5 d-E 11.5 d,叶酸组孕鼠连续灌胃给予叶酸(61.0 μg/(kg·d),SCH组孕鼠连续灌胃给予SCH(8.0 mg/(kg·d),1次/d;在E 11.5 d实行剖宫产手术取出胎鼠。将PC12细胞分为对照组、模型组与SCH组,模型组采用atRA(20 μmol/L)处理12 h建立细胞损伤模型,SCH组再使用SCH(2.5 μmol/L)处理24 h。体视显微镜下鉴定胎鼠NTDs;HE染色观察胎鼠神经管闭合情况;Western blotting检测磷脂酰肌醇-3-激酶/蛋白激酶B (PI3K/Akt)信号通路p-PI3K、Akt、p-Akt蛋白表达水平。,结果,2,与对照组比较,模型组胎鼠NTDs发病率明显升高(,P,<,0.01);与模型组比较,叶酸组和SCH组胎鼠NTDs发病率降低(,P,<,0.01);与叶酸组比较,SCH组胎鼠NTDs发病率降低(,P,<,0.01)。Western blotting检测结果显示,与对照组比较,模型组胎鼠组织p-PI3K、p-Akt蛋白表达均明显降低(,P,<,0.01,,P,<,0.05);与模型组比较,叶酸组胎鼠组织p-PI3K、p-Akt蛋白表达差异无统计学意义(,P,>,0.05),SCH组p-PI3K、p-Akt蛋白表达明显增高(,P,<,0.05)。与对照组比较,模型组PC12细胞p-PI3K、p-Akt蛋白表达水平降低(,P,<,0.05);与模型组比较,SCH组PC12细胞p-PI3K、p-Akt蛋白表达水平增高(,P,<,0.05)。,结论,2,SCH可降低atRA导致的胎鼠NTDs发病率,其预防效果优于叶酸,这可能与激活PI3K/Akt信号通路有关。
Objective,2,To investigate the preventive effect of schisandrin (SCH) on fetal neural tube defects (NTDs) of mice and its mechanism.,Methods,2,C57BL/6 mice were mated with female and male at a ratio of 2:1. Pregnant female mice with vaginal plug after mating were randomly divided into control group, model group, SCH group, and folic acid group, with 9 mice in each group. The NTDs fetal mice model was induced by intraperitoneal injection of all-trans retinoic acid (atRA) (7.5 mg/kg) on embryonic day 7.5 (E 7.5 d). During E 0.5 d-E 11.5 d, pregnant rats in folic acid group were given folic acid [61.0 μg/(kg·d)] by gavage once a day, and pregnant rats in SCH group were given SCH [8.0 mg/(kg·d)] by gavage once a day. Fetal mice were removed by cesarean section on E 11.5 d. PC12 cells were divided into control group, model group and SCH group. PC12 cells were treated with atRA (20 μmol/L) for 12 hours to establish cell damage model in model group, and treated with SCH (2.5 μmol/L) for 24 hours in SCH group. Fetuses were identified NTDs by stereoscopic microscopy. HE staining was used to observe the closure of the neural tube. The expression levels of p-PI3K, Akt and p-Akt molecules in PI3K/Akt signaling pathway were detected by Western Blotting.,Results,2,Compared with control group, the incidence of NTDs was significantly increased in mice of model group (,P,<,0.01); compared with model group, the incidence of NTDs was decreased in folic acid group and SCH group (,P,<,0.01); compared with folic acid group, SCH group had a lower incidence of NTDs (,P,<,0.01). Western Blotting results showed that compared with control group, the expression of p-PI3K and p-Akt protein in fetal tissues of model group was significantly decreased (,P,<,0.01,P,<,0.05); compared with model group, there was no significant difference in expression of p-PI3K and p-Akt in fetal tissues of folic acid group (,P,>,0.05), while the expression of p-PI3K and p-Akt protein in SCH group was significantly higher (,P,<,0.05). Compared with control group, PC12 cells in model group showed lower expression levels of p-PI3K and p-Akt (,P,<,0.05); compared with model group, PC12 cells in SCH group showed higher expression levels of p-PI3K and p-Akt (,P,<,0.05).,Conclusions,2,SCH can reduce the incidence of atRA-induced NTDs in fetal mice, and its preventive effect is better than folic acid, which may be related to the activation of the PI3K/Akt signaling pathway.
神经管畸形五味子醇甲PI3K/Akt信号通路预防
neural tube defectsschisandrinPI3K/Akt signaling pathwayprevention
Lin S, Ren A, Wang L, et al. Aberrant methylation of Pax3 gene and neural tube defects in association with exposure to polycyclic aromatic hydrocarbons[J]. Clin Epigenetics, 2019, 11(1): 13.
Zaganjor I, Sekkarie A, Tsang BL, et al. Describing the prevalence of neural tube defects worldwide: a systematic literature review[J]. PLoS One, 2016, 11(4): e0151586.
Wolujewicz P, Steele JW, Kaltschmidt JA, et al. Unraveling the complex genetics of neural tube defects: From biological models to human genomics and back[J]. Genesis, 2021, 59(11): 23459.
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group[J]. Lancet, 1991, 338(8760): 131-137.
An YX, Wang JH, Zhong RG. The research progress of PI3K/AKT pathway and neural tube decelopment[J]. Chin J Birth Health Hered, 2016, 24(10): 1-3, 9.
安彦新, 王建华, 钟儒刚. PI3K/Akt通路与神经管发育的研究进展[J]. 中国优生与遗传杂志, 2016, 24(10): 1-3, 9.
Liu S. Patuogenesis mechanisn on PI3K/Akt signaling pathway in neural tube defects under inositol imbalance[D]. Beijing: Beijing University of Technology, 2016.
刘赛. 肌醇失衡PI3K/Akt信号通路在神经管发育中的作用机制研究[D]. 北京: 北京工业大学, 2016.
Matsumoto T, Takiyama M, Sakamoto T, et al. Pharmacokinetic study of Ninjin'yoeito: absorption and brain distribution of Ninjin'yoeito ingredients in mice[J]. Ethnopharmacol, 2021, 279: 114332.
Zhang RJ, Hao HY, Liu QJ, et al. Protective effects of schisandrin on high glucose-induced changes of RhoA and eNOS activity in human umbilical vein endothelial cells[J]. Pathol Res Pract, 2018, 214(9): 1324-1329.
Cheng HY, Hsieh MT, Wu CR, et al. Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity[J]. Pharmacol Sci, 2008, 107(1): 21-31.
Yan T, Liu B, Li F, et al. Schizandrin ameliorates behavioral disorders in hepatic injury mice via regulation of oxidative stress and neuroinflammation[J]. Immunopharmacol Immunotoxicol, 2021, 43(2): 212-222.
Sowndhararajan K, Deepa P, Kim M, et al. An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis[J]. Biomed Pharmacother, 2018, 97: 958-968.
Wei BB, Liu MY, Chen ZX, et al. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain[J]. Acta Pharmacol Sin, 2018, 39(4): 616-625.
Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer[J]. Phytother Res, 2006, 20(5): 424-425.
Song L, Piao ZY, Zhang LM, et al. Effects of schisandrin on learning and memory and NF-κB p65 in APP/PS1 mice[J]. Chin Arch Tradit Chin, 2020, 38(2): 180-183, 287.
宋琳, 朴钟源, 张丽梅, 等. 五味子醇甲对APP/PS1小鼠学习记忆和NF-κB p65的影响[J]. 中华中医药学刊, 2020, 38(2): 180-183, 287.
Yan TX, Sun Y, Gong GW, et al. The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/Akt and IKK/IκBα/NF-κB pathway[J]. Experim Gerontol, 2019, 128: 110743.
Wei BB, Liu MY, Chen ZX, et al. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain[J]. Acta Pharmacol Sin, 2018, 39(4): 616-625.
Lin S, Ren A, Wang L, et al. Aberrant methylation of Pax3 gene and neural tube defects in association with exposure to polycyclic aromatic hydrocarbons[J]. Clin Epigenetics, 2019, 11(1): 13.
Yu J. The mechanisms of histone methylation modification in retinic acid-induced neural tube defects[D]. Taiyuan: Shanxi Medical University, 2017.
于娟. 组蛋白甲基化修饰在维甲酸致神经管畸形发生中的作用及分子机制研究[D]. 太原: 山西医科大学, 2017.
Lin H. China Report on the Prevention and Control of Birth Defects (2012) released by the Ministry of Health[J]. Chin Mod Med, 2012, 19(28): 1.
凌寒. 卫生部发布《中国出生缺陷防治报告(2012)》[J]. 中国当代医药, 2012, 19(28): 1.
Gu X, Lin LM, Zheng XY, et al. High prevalence of NTDs in Shanxi Province: a combined epidemiological approach[J]. Birth Defects Res A Clin Mol Teratol, 2017, 79(10): 702-707.
Wang Jf, Liu X, George C, et al. Assessing local determinants of neural tube defects in the Heshun Region, Shanxi Province, China[J]. BMC Public Health, 2015, 10(1): 52-63.
Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies[J]. Lancet Neurol, 2013, 12(8): 799-810.
Wang XW, Wang JH, Niu B. A review on the neural tube defects animal model[J]. Chin J Birth Health Hered, 2011, 19(2): 4-6.
王秀伟, 王建华, 牛勃. 神经管畸形动物模型的研究进展[J]. 中国优生与遗传杂志, 2011, 19(2): 4-6.
Wang F, Xu C, Reece EA, et al. Protein kinase C-alpha suppresses autophagy and induces neural tube defects via mir-129-2 in diabetic pregnancy[J]. Nat Commun, 2017, 8: 15182.
Yacob A, Carr CJ, Foote J, et al. The global burden of neural tube defects and disparities in neurosurgical care[J]. World Neurosurg, 2021, 149: 803-820.
Liu J, Zhou R, He Q, et al. Calmodulin kinase II activation of mitogen-activated protein kinase in PC12 cell following all-trans retinoic acid treatment[J]. J Neurotoxicol, 2009, 30(4): 599-604.
Wei X, Li H, Miao J, et al. Disturbed apoptosis and cell proliferation in developing neuroepithelium of lumbo-sacral neural tubes in retinoic acid-induced spina bifida aperta in rat[J]. J Int J Dev Neurosci, 2012, 30(5): 375-381.
Leck I. Causation of neural tube defects: clues from eipdemiology[J]. J Br Med Bull, 2017, 30(2): 158-163.
Yang CJ, Fan HJ, Chai Z, et al. Mechanism of Wuzi Yanzong Pill in preventing neural tube defects[J]. J Basic Chin Med, 2021, 27(12): 1887-1891.
杨婵娟, 樊慧杰, 柴智, 等. 五子衍宗丸预防神经管畸形的机制研究[J]. 中国中医基础医学杂志, 2021, 27(12): 1887-1891.
Ru Y, Fan HJ, Chai Z, et al. Progress of research on the pharmacological effects of schisandrin on central nervous system[J]. Chin Arch Tradit Chin Med, 2022, 40(7): 182-185.
茹意, 樊慧杰, 柴智, 等. 五味子醇甲对中枢神经系统药理作用研究进展[J]. 中华中医药学刊, 2022, 40(7): 182-185.
Wang XL, Chai Z, Gong Q, et al. To investifate the molecular mechanism of Wuzi Yanzong Pill in prevention and control of Neural Tube Defects based on Network Pharmacology[J]. Lishizhen Med Mater Med, 2022, 33(7): 1765-1768.
王新亮, 柴智, 弓强, 等. 基于网络药理学探讨五子衍宗丸防控神经管畸形的分子机制[J]. 时珍国医国药, 2022, 33(7): 1765-1768.
Dong QJ, Zhou Y, Fen W, et al. Application of fingerprint combined with QAMS in quality evaluation of Wuzi Yanzong Pills[J]. J Chin Med Mater, 2019, 42(3): 579-583.
董秋菊, 周园, 冯薇, 等. 指纹图谱结合一测多评法在五子衍宗丸质量评价中的应用[J]. 中药材, 2019, 42(3): 579-583.
Chinese Pharmacopoeia Commission. Pharmacopoeia of People's Republic of China:One[M]. Beijing: China Medical Science Press, 2015: 611-612.
国家药典委员会. 中华人民共和国药典: 一部[M]. 北京: 中国医药科技出版社, 2015: 611-612.
Li JT, Zhang T, Xie J. Preliminary study on the regulatory mechanism of Gcm1 affecting Wnt β-catenin signaling pathway by folate deficiency and its role in neural tube defects[C]//Proceedings of the 8th Pan-Rim Bohai Society for Biochemistry and Molecular Biology 2018 Academic Exchange Conference. 2018.
李建婷, 张霆, 解军. 叶酸缺乏对Gcm1影响Wntβ-catenin信号通路的调控机制及其在神经管畸形中的初步研究[C]//第八届泛环渤海生物化学与分子生物学会2018年学术交流会论文集. 2018.
Mukhopadhyay P, Greene RM, Pisano MM. MicroRNA targeting of the non-canonical planar cell polarity pathway in the developing neural tube[J]. Cell Biochem Funct, 2020, 38(7): 905-920.
Ybot-gonzalez P, Cogram P, Gerrelli D, et al. Sonic hedgehog and the molecular regulation of mouse neural tube closure[J]. Development, 2002, 129(10): 2507-2517.
Li H, Zhang J, Chen S, et al. Genetic contribution of retinoid-related genes to neural tube defects[J]. Hum Mutat, 2018, 39(4): 550-562.
Yokoyama K, Tatsumi Y, Hayashi K, et al. Effects of ursodeoxycholic acid and insulin on palmitate-induced ROS production and down-regulation of PI3K/Akt signaling activity[J]. Biol Pharm Bull, 2017, 40(11): 2001-2004.
Cao S, Reece EA, Shen Wb, et al. Restoring BMP4 expression in vascular endothelial progenitors ameliorates maternal diabetes-induced apoptosis and neural tube defects[J]. Cell Death Dis, 2020, 11(10): 859.
Gao L, Chen R, Sun ZH, et al. Neuroprotective effect of vitexin in rats with traumatic brain injury by regulating PI3K/Akt pathway[J]. Drugs Clin, 2021, 36(11): 2224-2230.
高亮, 陈瑞,孙志华, 等. 牡荆素调控PI3K/Akt通路对脑外伤大鼠的神经保护作用研究[J]. 现代药物与临床, 2021, 36(11): 2224-2230.
Lu LD, Wang YY. Research progress of experimental research with traditional Chinese medicine in the treatment of Parkinson's disease based on PI3K/Akt/mTOR signal pathway[J]. Clin J Tradit Chin Med, 2022, 34(2): 372-376.
陆连第, 王义义. 基于PI3K/Akt/mTOR 信号通路中药治疗帕金森病的实验研究进展[J]. 中医药临床杂志, 2022, 34(2): 372-376.
Xue M, Huang C. PI3K/Akt signaling pathway mediated by BDNF in treatment of nruropathic pain[J]. J Gannan Med Univ, 2021, 41(4): 327-33.
薛梦, 黄诚. BDNF介导PI3K/Akt信号通路在神经病理性疼痛中的作用及干预研究进展[J]. 赣南医学院学报, 2021, 41(4): 327-331.
Li H, Tang Z, Chu P, et al. Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: involvement of dual PI3K/Akt and Nrf2/HO-1 pathways[J]. Free Radic Biol Med, 2018, 120: 228-238.
Le AW, Shan LL, Dai XY, et al. PI3K, AKT, and P-AKT levels in thin endometrium[J]. Genet Mol Res, 2016, 15(1): 7184.
Yan TX, Sun Y, Gong GW, et al. The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF‑κB pathway[J]. Exp Gerontol, 2019, 128: 110743.
0
Views
0
下载量
0
CSCD
0
CNKI被引量
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621